Reduction in the frequency of mutation to resistance to cytarabine in L1210 murine leukemic cells by treatment with quinacrine hydrochloride.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use*; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009154:Mutation / Q000187:drug effects*; D011796:Quinacrine / Q000008:administration & dosage / Q000494:pharmacology*
D003561:Cytarabine; D011796:Quinacrine